Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | OKUR | SNSE | ||
| Company | Catabasis Pharma | Onkure Therapeutics Inc | Sensei Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 2.42 | 28.00 | ||
| High | 9.21 | 2.55 | 31.94 | ||
| Low | 8.46 | 2.40 | 22.07 | ||
| Latest | 8.54 | 2.48 | 26.25 | ||
| Change | -0.64 | +0.08 | +17.12 | ||
| % Change | -6.97% | +3.33% | +187.51% | ||
| Volume | 98,800 | 130,300 | 12,540,601 | ||
| 20-Day Average Volume | 395,311 | 93,090 | 685,580 | ||
| Previous Close | 9.18 | 2.40 | 9.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 2.61 | 10.27 | ||
| 20-Day Raw Stochastic | 56.46% | 25.51% | 75.86% | ||
| 20-Day Relative Strength | 43.24 | 43.05 | 85.30 | ||
| Weighted Alpha | -50.43 | -41.15 | +35.82 | ||
| Today's Opinion | 88% Sell | 56% Sell | 100% Buy | ||
| Previous Opinion | 72% Sell | 56% Sell | 16% Sell | ||
| Last Month's Opinion | 100% Sell | 80% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | -1.20% since 02/10/26 | +197.62% since 02/10/26 | ||
| Low | 8.46 on 09/08/21 | 2.35 on 02/12/26 | 8.72 on 02/11/26 | ||
| High | 10.26 on 09/02/21 | 2.59 on 02/13/26 | 31.94 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -17.33% since 01/16/26 | +151.44% since 01/16/26 | ||
| Low | 6.31 on 08/20/21 | 2.23 on 02/04/26 | 8.37 on 02/05/26 | ||
| High | 10.26 on 09/02/21 | 3.21 on 01/27/26 | 31.94 on 02/18/26 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -15.36% since 11/18/25 | +207.41% since 11/18/25 | ||
| Low | 6.31 on 08/20/21 | 2.23 on 02/04/26 | 7.45 on 12/05/25 | ||
| High | 15.72 on 06/16/21 | 3.52 on 12/08/25 | 31.94 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -11.43% since 08/18/25 | +217.41% since 08/18/25 | ||
| Low | 6.31 on 08/20/21 | 2.23 on 02/04/26 | 7.21 on 08/20/25 | ||
| High | 22.01 on 03/18/21 | 3.63 on 10/28/25 | 31.94 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 33,599 | 33,109 | ||
| Shares Outstanding, K | 3,904 | 13,548 | 1,261 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -37,300,000 | -52,670,000 | -30,160,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -7,470,000 | -14,700,000 | -4,570,000 | ||
| 60-Month Beta | 1.66 | 0.46 | 0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.09 on 11/06/25 | -3.62 on 11/14/25 | ||
| Latest Earnings Date | 11/11/21 | 03/09/26 | 03/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||